Abstract
IntroductionTo date, there is no broadly accepted dementia risk score for use in individuals with mild cognitive impairment (MCI), partly because there are few large datasets available for model development. When evidence is limited, the knowledge and experience of experts becomes more crucial for risk stratification and providing MCI patients with prognosis. Structured expert elicitation (SEE) includes formal methods to quantify experts’ beliefs and help experts to express their beliefs in a quantitative form, reducing biases in the process. This study proposes to (1) assess experts’ beliefs about important predictors for 3-year dementia risk in persons with MCI through SEE methodology and (2) to integrate expert knowledge and patient data to derive dementia risk scores in persons with MCI using a Bayesian approach.Methods and analysisThis study will use a combination of SEE methodology, prospectively collected clinical data, and statistical modelling to derive a dementia risk score in persons with MCI . Clinical expert knowledge will be quantified using SEE methodology that involves the selection and training of the experts, administration of questionnaire for eliciting expert knowledge, discussion meetings and results aggregation. Patient data from the Prospective Registry for Persons with Memory Symptoms of the Cognitive Neurosciences Clinic at the University of Calgary; the Alzheimer’s Disease Neuroimaging Initiative; and the National Alzheimer’s Coordinating Center’s Uniform Data Set will be used for model training and validation. Bayesian Cox models will be used to incorporate patient data and elicited data to predict 3-year dementia risk.DiscussionThis study will develop a robust dementia risk score that incorporates clinician expert knowledge with patient data for accurate risk stratification, prognosis and management of dementia.
Funder
Alberta Innovates Graduate Student Scholarship 2019
Cumming School of Medicine Graduate Scholarship
Natural Sciences and Engineering Research Council of Canada
Harley N. Hotchkiss Doctoral Scholarship in Neuroscience
Reference46 articles.
1. Prince M , Wimo A , Guerchet M . World Alzheimer Report. In: The global impact of dementia: an analysis of prevalence, incidence, cost and trends. 87, 2015.
2. Public Health Agency of Canada . Dementia in Canada, Including Alzheimer’s Disease. Available: https://www.canada.ca/en/public-health/services/publications/diseases-conditions/dementia-highlights-canadian-chronic-disease-surveillance.html
3. Public Health Agency of Canada . Mapping connections: an understanding of neurological conditions in Canada, 2018. Available: https://www.canada.ca/en/public-health/services/reports-publications/mapping-connections-understanding-neurological-conditions.html
4. Conversion to dementia from mild cognitive disorder: The Cache County Study
5. Incidence of mild cognitive impairment in the Pittsburgh Cardiovascular Health Study-Cognition Study
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献